English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 9 July 2025, 20:32 HKT/SGT
Share:
    

Source: Cornerstone Robotics
Cornerstone Robotics Launches First Clinical Evaluation of its Hong Kong-Developed Surgical Robotic System in UK

HONG KONG, July 9, 2025 - (ACN Newswire) - Cornerstone Robotics (CSR) has announced the first formal clinical investigation of its Hong Kong-developed surgical robotic system at Portsmouth Hospitals University NHS Trust (PHU), Portsmouth, UK.  The Sentire® Endoscopic Surgical System (C1000), developed by Hong Kong-based Cornerstone Robotics Limited, is now being evaluated at PHU’s Queen Alexandra Hospital in Portsmouth, UK.

This groundbreaking initiative represents the first clinical deployment of the Sentire® System in the UK and Europe, a major milestone in international clinical collaboration that marks the start of Cornerstone’s preparations for commercial activities in the region.

Led by Professor Jim Khan, PHU’s surgical team kicked off the start of the clinical trial with three successful colorectal procedures using the Sentire® system.

The clinical investigation is focused on assessing the safety and efficacy of the Sentire® system for performing colorectal and urological procedures within European populations—expanding upon previous clinical data generated in Asia.  The trial follows international standards for device evaluation, marking a significant regulatory and clinical first for a Chinese robotic platform.

“I was particularly impressed by how quickly our team adapted to the Sentire® Surgical System,” said Professor Jim Khan, Chief Investigator. “The platform performed smoothly and reliably.  I’d like to thank the Cornerstone team for their outstanding support throughout this pioneering phase.”

Professor Samuel Au, CEO of Cornerstone Robotics, commented: “This is a proud moment for our company and for the broader innovation ecosystem in Hong Kong.  We are honoured to partner with PHU in launching this CSR’s first investigation in the UK.  We believe the results will further validate the capabilities of the Sentire® Endoscopic Surgical System and help deliver greater accessibility and efficiency in surgical robotics in the UK, EU, and beyond.”

The Sentire® Endoscopic Surgical System combines clinical workflows with integrated engineering, software, and imaging technologies to support surgeons in performing intricate minimally invasive procedures.  Early clinical feedback suggests that these features may contribute to streamlined workflows for surgical teams and improved outcomes for patients.

This collaboration reinforces PHU’s position at the forefront of surgical robotics.  PHU is the first in the UK to operate a dedicated robotic-assisted day surgery programme and has performed over 5,000 robotic procedures across colorectal, urological, upper gastrointestinal, and gynaecological specialities - offering a scalable model for NHS adoption of advanced surgical technology.

About Portsmouth Hospitals University NHS Trust (PHU)

Portsmouth Hospitals University NHS Trust (PHU) delivers acute hospital services to over 675,000 people across Hampshire.  Based at Queen Alexandra Hospital, PHU is an international leader in surgical robotics, having pioneered minimally invasive surgery since early the 2000s.

PHU has been of the earliest adopters of robotics since 2012 and has completed more than 5,000 robotic procedures across multiple specialties helping to redefine surgical care across the NHS. PHU also leads research in clinical robotics with the adoption of the UK’s first robotic-assisted day case surgery programme.  

About Cornerstone Robotics Limited (CSR)

Cornerstone Robotics (CSR) is leading medical innovations to create a healthier world by advancing surgical care with cutting-edge robotic systems that make high-quality healthcare more accessible and efficient for everyone globally.  Founded in 2019, CSR has assembled a global team of surgical robotics experts, clinical professionals, and multidisciplinary innovators, driving rapid growth with key hubs in Hong Kong, Shenzhen, Beijing, Shanghai, Boston (USA), and Amsterdam (NL), alongside an R&D collaboration hub in Portsmouth (UK). With multiple development pipelines, we are pioneering robotic solutions for soft tissue and other surgical specialties. See https://en.csrbtx.com.

Contact:
Cornerstone Robotics Limited
E-mail  support@csrbtx.com



Topic: Corporate Announcement
Source: Cornerstone Robotics

Sectors: Healthcare & Pharm, MedTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Cornerstone Robotics Related News
July 17, 2025 18:45 HKT/SGT
Cornerstone Robotics Signs MOU with NHG Health and NTU Singapore to Facilitate Accessibility of RAS to Patients in Singapore
July 17, 2025 17:27 HKT/SGT
康諾思騰與新加坡國立健保集團及南洋理工大學簽署三方戰略合作備忘錄
July 17, 2025 17:14 HKT/SGT
康诺思腾与新加坡国立健保集团及南洋理工大学签署三方战略合作备忘录
July 9, 2025 20:35 HKT/SGT
康诺思腾自主创新研发的手术机器人 成功于英国启动首轮临床试验
July 9, 2025 20:32 HKT/SGT
康諾思騰自主創新研發的手術機械人 成功於英國啟動首輪臨床試驗
More news >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575